![]() |
|
|
Vol. 280, Issue 2, 846-853, 1997
School of Pharmacy, Mercer University and School of Chemistry and
Biochemistry, Georgia Institute of Technology, Atlanta, Georgia
4-Phenyl-3-butenoic acid (PBA) has been shown in vitro
to be a turnover-dependent inactivator of peptidylglycine
-monoooxygenase (PAM), the rate-limiting enzyme involved in the
formation of amidated neuropeptides from their glycine-extended
precursors. In the studies reported herein, we have shown that PBA
produces a dose-dependent (50-500 mg/kg s.c.) inhibition of serum PAM
activity in normal rats without affecting peptidylamidoglycolate lyase
activity. Because amidated neuropeptides such as substance P and
calcitonin gene-related peptide are involved in acute inflammation, we
evaluated the effects of PBA on carrageenan-induced inflammation in
rats. The acute administration of PBA (s.c. or i.p.) produced a
dose-related inhibition of edema with maximum inhibition (67%)
observed at 2 hr postphlogistic agent. In addition, the continuous
administration of PBA to animals over a 7-day period using osmotic
pumps not only inhibited hind paw swelling induced by carrageenan but
also inhibited serum PAM activity and reduced tissue levels of
substance P in hind paws. These results demonstrate for the first time
a correlation between the antiinflammatory activity produced by an
inhibitor of peptide amidation with its ability to inhibit serum PAM
activity and lower endogenous tissue levels of substance P. Moreover,
these results confirm our contention that PAM is an excellent
pharmacological target for controlling the acute inflammatory response.
We also demonstrate the ability of PBA to inhibit phenyl-p-quinone and
acetylcholine-induced writhing in mice without affecting the spinally
mediated tail immersion assay in rats. Because this analgesic effect
was extremely rapid (within 15 min), PBA may be producing this effect
by a mechanism other than peptide amidation.
This article has been cited by other articles:
![]() |
J. D. Bauer, J. A. Sunman, M. S. Foster, J. R. Thompson, A. A. Ogonowski, S. J. Cutler, S. W. May, and S. H. Pollock Anti-Inflammatory Effects of 4-Phenyl-3-butenoic Acid and 5-(Acetylamino)-4-oxo-6-phenyl-2-hexenoic Acid Methyl Ester, Potential Inhibitors of Neuropeptide Bioactivation J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1171 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Mueller, W. J. Driscoll, and B. A. Eipper In Vivo Inhibition of Peptidylglycine-alpha -Hydroxylating Monooxygenase by 4-Phenyl-3-Butenoic Acid J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1331 - 1336. [Abstract] [Full Text] |
||||